Logo-ps

Submitted: 30 Jun 2026
Revision: 27 Jul 2026
Accepted: 27 Jul 2026
ePublished: 29 Jul 2026
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Pharm Sci. 2026;32(4): 650.
doi: 10.34172/ps.44333
  Abstract View: 286
  PDF Download: 101

Corrigendum

Protective Effects of Silymarin on Gentamicin-Induced Nephrotoxicity in Infectious Patients: A Randomized Double Blinded Placebo-Controlled Clinical Trial

Motahareh Mahi-Birjand 1,2 ORCID logo, Iman Karimzadeh 3, Asghar Zarban 4, Meghdad Abdollahpour-Alitappeh 5, Seyed Alireza Saadatjoo 6, Masood Ziaee 1* ORCID logo

1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Student Research Committee, Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Science, Shiraz, Iran
3 Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Science, Shiraz, Iran
4 Department of Clinical Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
5 Cellular and Molecular Biology Research Center, Larestan University of Medical Sciences, Larestan, Iran
6 Department of Nursing, Birjand University of Medical Sciences, Birjand, Iran
*Corresponding Author: Masood Ziaee, Email: dr.m.ziaee@gmail.com

Abstract

In the published article, “Mahi-Birjand M, Karimzadeh I, Zarban A, Abdollahpour-Alitappeh M, Saadatjoo SA, Ziaee M. Protective effects of silymarin on gentamicin-induced nephrotoxicity in infectious patients: a randomized double blinded placebo-controlled clinical trial. Pharmaceutical Sciences. 2020;26(3):287-95. doi: 10.34172/PS.2020.33”. The ethics approval code should be corrected from IR.SUMS.REC.1397.330 to IR.SUMS.REC.1397.329 and The IRCT registration number should be corrected to IRCT20161010030246N3 and the study start date should be corrected from April 2017 to November 2018. These corrections are administrative in nature and do not affect the study design, methodology, results, interpretation, or conclusions of the article. The authors apologize for any inconvenience this may have caused.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 287

Your browser does not support the canvas element.

PDF Download: 101

Your browser does not support the canvas element.